Evaluation of prostate specific membrane antigen (PSMA) as a radiotherapeutic target in glioblastoma multiforme (GBM) Grant uri icon

Overview

date/time interval

  • January 1, 2024 -

sponsor award ID

  • RSNA 230525-01

Affiliation